Showing results (71-80 of 2,294) with videos related to
Sort By:
Pageof 230
Journal of Medicinal Chemistry|December 1, 1985
Stereoselectivity of muscarinic receptors in vivo and in vitro for oxotremorine analogues. N-[4-(tertiary amino)-2-butynyl]-5-methyl-2-pyrrolidonesR Amstutz, B Ringdahl, B Karlén, et al.Annals of Neurology|February 1, 1979
Metabolism of dimethoxymethyl phenobarbital (eterobarb) in patients with epilepsyM A Goldberg, J Gal, A K Cho, et al.Journal De Physiologie|January 1, 1984
Electrophysiological and neurochemical investigations of the action of presynaptic neurotoxinsC B Gundersen, D J Jenden, R Miledi, et al.Electroencephalography and Clinical Neurophysiology|July 1, 1981
Drug-specific EEG frequency spectra and their time courses produced in the cat by antidepressants and a benzodiazepineM D Fairchild, D J Jenden, M R Mickey, et al.Psychopharmacology|January 31, 1978
The attenuation of a specific cue-to-consequence association by antiemetic agentsJ D Coil, W G Hankins, D J Jenden, et al.Pharmacology, Biochemistry, and Behavior|March 1, 1987
Influence of atropine and N-methyl atropine pretreatments on behavioral and physiological effects of the irreversible muscarinic agonist, BM123D H Overstreet, R W Russell, R A Booth, et al.Brain Research Bulletin|January 1, 1997
Cholinesterase inhibition improves blood flow in the ischemic cerebral cortexO U Scremin, M G Li, A M Scremin, et al.Acta Geneticae Medicae Et Gemellologiae|January 1, 1983
Behavioral responses to amphetamines in identical twinsJ C Crabbe, L F Jarvik, E H Liston, et al.Brain Research Bulletin|January 27, 1998
Mapping of cerebral metabolic activation in three models of cholinergic convulsionsO U Scremin, T M Shih, M G Li, et al.Neurobiology of Aging|January 1, 1985
Further characterizations of the nature of the behavioral and neurochemical effects of lesions to the nucleus basalis of Meynert in the ratH J Altman, R D Crosland, D J Jenden, et al.Pageof 230